Reporting owner · CIK 0002050755

Reprogrammed Interchange LLC

Visual SEC Form 4 history across 1 companies, 2 transactions and 1 filings.

10%Vor Biopharma Inc.
Open-market mix
Filings1Form 4 records
Buying2 purchases
Selling$00 sales
Net value$0Buys minus sells
Companies12 securities
Most recentDec 30, 2024buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-52Dec 24

Net value flow

Buys minus sells

Dec 24

Transaction texture

Ownership and ticket size

Average P/S size
Median P/S size
Direct2
Indirect0
Dec 30, 2024buy

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at Vor Biopharma Inc. on Dec 30, 2024 with an unknown reported value.

Review SEC filing
Latest buy

buy at Vor Biopharma Inc. on Dec 30, 2024 with an unknown reported value.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

Reprogrammed Interchange LLC Insider Activity FAQ

SEC Form 4 context

Who is Reprogrammed Interchange LLC?

Reprogrammed Interchange LLC is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002050755.

Which companies has Reprogrammed Interchange LLC reported transactions for?

Vor Biopharma Inc.

When was Reprogrammed Interchange LLC's latest insider buy?

buy at Vor Biopharma Inc. on Dec 30, 2024 with an unknown reported value.

When was Reprogrammed Interchange LLC's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.